About
Basaglar KwikPen contains insulin glargine, a long-acting human insulin analog specifically engineered to provide a constant, peakless basal insulin level over a full 24-hour period. This sustained action is crucial for effectively controlling blood sugar levels between meals and overnight, mimicking the body's natural basal insulin secretion. Insulin glargine is produced through recombinant DNA technology, and its unique amino acid sequence allows it to form microprecipitates upon subcutaneous injection. This precipitation leads to a slow and consistent release of insulin into the bloodstream, ensuring prolonged glucose-lowering effects. It is a cornerstone therapy indicated for improving glycemic control in both adults and children diagnosed with Type 1 Diabetes Mellitus, as well as in adults with Type 2 Diabetes Mellitus, providing a foundational insulin regimen to manage chronic hyperglycemia.
Uses
- Management of Type 1 Diabetes Mellitus.
- Management of Type 2 Diabetes Mellitus.
- To provide basal insulin requirements.
- To lower high blood sugar levels.
Directions For Use
Inject subcutaneously once daily at the same time each day. Rotate injection sites within the same region to reduce the risk of lipodystrophy.
Benefits
- Provides sustained blood sugar control for 24 hours.
- Reduces the risk of nocturnal hypoglycemia compared to NPH insulin.
- Convenient once-daily dosing.
- Helps prevent long-term diabetes complications.
- Mimics natural basal insulin secretion.
- Suitable for both Type 1 and Type 2 diabetes.
Side Effects
- Hypoglycemia (low blood sugar)
- Injection site reactions (pain, redness, swelling)
- Lipodystrophy (fat atrophy or hypertrophy at injection site)
- Weight gain
- Peripheral edema
- Allergic reactions (rash, itching)
- Pruritus
- Urticaria
- Bronchospasm
- Hypokalemia (low potassium levels)
- Antibody formation
- Blurred vision (transient)
Safety Measures
- Alcohol - Alcohol can lower blood sugar and increase the risk of hypoglycemia when using insulin. Consume alcohol in moderation and with food.
- Pregnancy - Insulin is the preferred treatment for diabetes during pregnancy. Insulin glargine can be used under strict medical supervision.
- Breastfeeding - Insulin is generally considered safe during breastfeeding as it is unlikely to pass into breast milk in significant amounts.
- Liver - Patients with liver impairment may require closer monitoring and dose adjustments due to altered glucose metabolism and increased risk of hypoglycemia.
- Kidney - Patients with kidney impairment may require dose adjustments due to altered insulin clearance and increased risk of hypoglycemia.
- Lung - No specific contraindications or precautions related to lung conditions are typically noted for insulin glargine.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!